The Patent Finder

Compounds and Methods for Kinase Modulation, and Indications Therefor (2013)

Plexxikon Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2012/023543, filed Feb 1, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,624,213Compounds and Methods for Kinase Modulation, and Indications Therefor
In force
 · High confidence
UsedRemaining
Plexxikon Inc.In forceHigh confidence
US 12,076,322Compounds and Methods for Kinase Modulation, and Indications Therefor
In force
 · Medium confidence
Plexxikon Inc.In forceMedium confidence
US 11,337,976Compounds and Methods for Kinase Modulation, and Indications Therefor
In force
 · High confidence
Plexxikon Inc.In forceHigh confidence
Application 17/722,229Compounds and Methods for Kinase Modulation, and Indications Therefor
Abandoned
Abandoned Aug 29, 2022
Plexxikon Inc.AbandonedAbandoned Aug 29, 2022
Application 18/778,765Compounds and Methods for Kinase Modulation, and Indications Therefor
Pending
Not granted
Plexxikon Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Plexxikon Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited